NCT05783869Recruiting
Study of Bronchiectasis and Associated Cardiovascular Comorbidities
Effect of Cardiovascular Comorbidities on Disease Severity and Quality of Life in Patients With Acute Exacerbation of Non-cystic Fibrosis Bronchiectasis
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
Effect of cardiovascular comorbidities on disease severity and quality of life in Patients with acute exacerbation of non-cystic fibrosis bronchiectasis
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 12 Feb 2023
- Start date
- 25 Mar 2023
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Assiut University
- Diseases
- Cystic fibrosis
- NCT number
- NCT05783869
What you commit to
- Study type: Observational
- Planned participants: 30
- From 25 Mar 2023 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any other comorbidity or end-organ failure may affect the study's result.
Other
- Any Patients who refuse to participate in the study.
Who the study is looking for
- Any Patients with Bronchiectasis had no comorbidities other than cardiovascular comorbidities during the study period.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assiut unviresty - Faculty of Medicine Coordinator of this site? Confirm its status | Asyut | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.